Costs and effects associated with a community pharmacy-based smoking- cessation programme

PharmacoEconomics

Volumn 14, Issue 3, 1998, Pages 323-333

  Crealey, Grainne E ^a   McElnay, James C ^a   Maguire, Terry A ^a   O'Neill, Ciaran ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMMUNITY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COUNSELING; HEALTH SERVICE; HUMAN; LIFE EXPECTANCY; PHARMACY; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RELAPSE; SMOKING CESSATION; UNITED KINGDOM;

COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; PHARMACIES; SMOKING CESSATION;

EID: 0031713274     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199814030-00008     Document Type: Article

References (54)

1. Glantz SA, Parmley WW. Passive smoking and heart disease. Circulation 1991; 83: 1-10
2. O'Reilly D, Gavin AT. Cancer deaths in Northern Ireland: an analysis of patterns and trends. Belfast: Northern Ireland Cancer Registry, 1995
3. Doll R, Peto R, Wheatley K, et al. Mortality in relation to smoking: 40 years' observation on male British doctors. BMJ 1994; 309: 901-11
4. Peto R, Lopez A, Boreham J, et al. Mortality from tobacco in developed countries: indirect estimation from national vital statistics. Lancet 1992; 339: 1268-78
5. Eddy DM. David Eddy ranks the tests. Harv Health Lett 1992; Jul Suppl.: 10-11
6. Leu RE, Schaub T. Does smoking increase medical care expenditures? Soc Sci Med 1983; 17: 1907-14
7. Leu RE, Schaub T. Economic aspects of smoking. Eff Health Care 1984; 2: 11-123
8. Leu RE, Schaub T. More on the impact of smoking on medical care expenditures. Soc Sci Med 1985; 21: 825-7
9. Manning WG, Keeler EB, Newhouse JP, et al. The taxes of sin: do smokers and drinkers pay their way? JAMA 1989; 261: 1604-9
10. Stoddart GL, Labelle RJ, Barer ML, et al. Tobacco taxes and healthcare costs: do Canadians pay their way? J Health Econ 1986; 5: 63-80
11. Collingshaw NE, Myers G. Dollar estimates of the consequences of tobacco use in Canada. Can J Public Health 1984; 75: 192-9
12. Markandya A, Pearce DW. The social costs of tobacco smoking. Br J Addict 1989; 84: 1139-50
13. Phillips D, Kawachi I, Tilyard M. The costs of smoking revisited. N Z Med J 1992; 105: 240-3
14. Kristein MM. How much can business expect to profit from smoking cessation. Prev Med 1983; 12: 358-81
15. Atkinson AB, Meade TW. Methods and preliminary findings in assessing the economic and health consequences of smoking, with particular reference to lung cancer. J Royal Stat Soc Series A 1974; 137: 297-312
16. Rice DP, Hodgson TA, Sinsheimer P, et al. The economic costs of the health effects of smoking. Milbank Q 1986; 64: 489-547
17. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Q 1992; 70: 80-125
18. Oster G. Colditz GA, Kelly NL. The economic costs of smoking and benefits of quitting for individual smokers. Prev Med 1984; 13: 377-89
19. Oster G, Huse DM, Delea TE, et al. Cost effectiveness of nicotine gum as an adjunct to physicians' advice against cigarette smoking. JAMA 1986; 256: 1315-8
20. Warner KE. Health and economic implications of a tobacco tree society. JAMA 1987; 258: 2080-6
21. Kottke TE, Battista RN, DeFries GH, et al. Attributes of successful smoking cessation interventions in medical practice. JAMA 1988; 259: 2883-9
22. Elixhauser A. The costs of smoking and cost effectiveness of smoking-cessation programs. J Public Health Policy 1990; 11: 218-37
23. Jamrozik K, Vessey M, Fowler G, et al. Controlled trial of three different anti-smoking interventions in general practice. BMJ 1984; 288: 1499-502
24. Russel MAH, Wilson C, Taylor C, et al. Effect of general practitioner's advice against smoking. BMJ 1979; 2: 231-5
25. Russel MAH, Merrion R, Stappleton J, et al. Effect of nicotine chewing gum as an adjunct to general practitioner's advice against smoking. BMJ 1983; 287: 1782-5
26. Fragerstrom KA. Effect of nicotine chewing gum and follow up appointments in physician based smoking cessation. Prev Med 1984; 13: 517-27
27. Cummings KM, Giovino G, Emont SL, et al. Factors influencing success in counselling patients to stop smoking. Patient Educ Counsel 1986; 8: 189-200
28. Li V, Coates TJ, Ewart CK, et al. The effectiveness of smoking cessation advice given during routine medical care: physicians can make a difference. Am J Prev Med 1987; 3: 81-6
29. Shipley RH, Orlean CS. Treatment of cigarette smoking. In: Boudewyns PA, Keefe FJ, editors. Behavioural medicine in general medical practice. New York: Addison-Wesley, 1982
30. Burt A, Thornley P, Illingworth D, et al. Stopping smoking after myocardial infarction. Lancet 1974; 23: 304-6
31. Fragerstrom KO. A comparison of psychological and pharmacological treatment in smoking cessation. J Behav Med 1982; 5: 343-51
32. Jarvis MJ, Raw M, Russell MA, et al. Randomised controlled trial for nicotine chewing gum. BMJ 1982; 285: 537-40
33. Abelin T, Buehler A, Muller P, et al. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1989; 1: 7-10
34. Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up : one year outcome and percentage of nicotine replacement. JAMA 1994; 271: 595-600
35. Stapleton JA, Russell MA, Feyerabend C, et al. Dose effects and predictors of outcome in a randomised trial of transdermal nicotine patches in general practice. Addiction 1995; 90: 31-42
36. Tonnesen P, Noreguaard J, Simonsen K, et al. A double blind trial of a 16 hour transdermal nicotine patch in smoking cessation. N Engl J Med 1991; 325: 311-5
37. Wasley MA, McNagny SE, Phillips VL, et al. The cost effectiveness of the nicotine transdermal patch for smoking cessation. Prev Med 1997; 26: 264-70
38. Cummings SR, Rubin SM, Oster G. The cost-effectiveness of counselling smokers to quit. JAMA 1989; 261: 75-9
39. Fiscella K, Fanks P. Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counselling. JAMA 1996; 275; 1247-51
40. Krumholtz HM, Cohen BJ, Tsevat J, et al. Cost effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol 1993; 22: 1697-702
41. Altman DG, Flora JA, Fortman SP, et al. The cost effectiveness of three smoking cessation programs. Am J Public Health 1987; 77: 162-6
42. Windsor RA, Warner KE, Cutter GR. A cost effectiveness analysis of self help smoking cessation methods for pregnant women. Public Health Rep 1988; 103: 83-8
43. Danaher BG, Berkanovic E, Gerber B. Mass media based health behaviour change televised smoking cessation programme. Addict Behav 1984; 9: 245-53
44. Health and wellbeing: into the next millennium. Regional strategy for health and social wellbeing, 1997-2002. London: Department of Health and Social Services, 1997
45. Maguire TA. A study of the feasibility of a smoking cessation service in a community pharmacy [abstract]. Pharm J 1993; 251: R26
46. Evans D, Lane DS. Long term outcome of smoking cessation workshops. Am J Public Health 1980; 70: 725-7
47. Hunt WA, Besplac DA. An evaluation of current methods of modifying smoking behaviour. J Clin Psychol 1973; 30: 431-8
48. Drummond MF. Principals of economic appraisal in health care. Oxford: Oxford University Press, 1987
49. The smoking epidemic: counting the cost in Northern Ireland. London: Health Education Authority, 1991
50. Rogers RG, Powell-Griner E. Life expectancies of cigarette smokers and nonsmokers in the United States. Soc Sci Med 1991; 32: 1151-9
51. Drummond MF, Stoddart GL, Torrence GW. Methods for the economic evaluation of healthcare programmes. Oxford: Oxford University Press, 1987
52. Parsonage M, Neuberger H. Discounting and health benefits. Health Econ 1992; 1: 71-6
53. Phillips KA, Holtgrave DR. Using cost-effectiveness/cost benefit analysis to allocate health resources: a level playing field for prevention. Am J Prev Med 1997; 13 (1): 18-25
54. Her Majesty's Stationary Office (HMSO). Health of the nation. London: HMSO, 1992